2025 Latin America Artificial Intelligence (Ai) In Drug Discovery Market Revenue Opportunities Report
Description
The 2025 Latin America Artificial Intelligence (Ai) In Drug Discovery Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Artificial Intelligence (AI) in Drug Discovery Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the Artificial Intelligence (AI) in Drug Discovery market, including their influence related to Latin America, are Microsoft, Exscientia, BenevolentAI, and Isomorphic Labs. Microsoft is a major player in AI-driven drug discovery platforms, leveraging data to expedite drug target recognition and optimization. Exscientia specializes in AI for drug design and development, growing its presence through product innovations. BenevolentAI uses AI to improve drug development efficiency, collaborating broadly in pharma innovation. Isomorphic Labs, a Google DeepMind spin-off, focuses on deep learning and reinforcement learning techniques to solve complex drug discovery problems and has partnerships with large pharma companies like Novartis and Eli Lilly.
In Latin America, the AI in drug discovery market is developing rapidly, with government readiness in Brazil, Mexico, and Uruguay fostering adoption of AI technologies to improve oncology, neurodegenerative, cardiovascular, and infectious disease treatments. Although direct Latin American operations of these companies are less detailed, the growth potential in the region is significant due to AI's role in reducing R&D costs and time. Strategic market intelligence and collaborations indicate these global leaders are well-positioned to expand their impact in Latin America by supporting governments and institutions embracing AI-driven drug discovery.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Artificial Intelligence (AI) in Drug Discovery Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the Artificial Intelligence (AI) in Drug Discovery market, including their influence related to Latin America, are Microsoft, Exscientia, BenevolentAI, and Isomorphic Labs. Microsoft is a major player in AI-driven drug discovery platforms, leveraging data to expedite drug target recognition and optimization. Exscientia specializes in AI for drug design and development, growing its presence through product innovations. BenevolentAI uses AI to improve drug development efficiency, collaborating broadly in pharma innovation. Isomorphic Labs, a Google DeepMind spin-off, focuses on deep learning and reinforcement learning techniques to solve complex drug discovery problems and has partnerships with large pharma companies like Novartis and Eli Lilly.
In Latin America, the AI in drug discovery market is developing rapidly, with government readiness in Brazil, Mexico, and Uruguay fostering adoption of AI technologies to improve oncology, neurodegenerative, cardiovascular, and infectious disease treatments. Although direct Latin American operations of these companies are less detailed, the growth potential in the region is significant due to AI's role in reducing R&D costs and time. Strategic market intelligence and collaborations indicate these global leaders are well-positioned to expand their impact in Latin America by supporting governments and institutions embracing AI-driven drug discovery.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
